نتائج البحث 1421-1430 من 19771 لعملية البحث عن Two-phase
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
Actinium Therapy For Late-stage Aggressive Sarcomas ... The main questions the study aims to answer in Phase/Part 1 of the trial are: ... * For cycles 2-6: patient ...
Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA ... two cycles of mosunetuzumab. An additional arm ... MC1733, Phase I Trial of Intratumoral ...
Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase ... This phase I trial studies the best dose and side ... [1, 2] The solid tumor stroma acts as an ...
... (2) improves ... A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with Prader-Willi Syndrome ... The study has two arms: a “longitudinal arm ...
... two lines of therapy as measured by objective ... A Study to Evaluate Immune-related Biomarkers for Pathological Response in Stage II-III HER2-positive Breast ...
In this study, we make and test preclinical models of gynecological cancers (ovarian, fallopian tube, peritoneal, uterine, vulvar, cervix, and vaginal) of any ...
عرض 1-2 خارج الأطباء 2 المتاحين. الحرف الأول من اسم العائلة: S. Rory L. Smoot, M.D.. Surgical Oncologist; Hepatobiliary and Pancreas Surgeon.
Rochester, Minn. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...
... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.